Werewolf Therapeutics Inc
HOWL’s short interest reaches 1.03 million shares on 2025-11-28
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...
Werewolf Therapeutics Inc [HOWL] Investment Appeal on the Rise
Werewolf Therapeutics Inc’s filing revealed that its Director EVNIN LUKE unloaded Company’s shares for reported $38198.0 on Nov 26 ’25. ...
Werewolf Therapeutics Inc (HOWL) receives a Mkt outperform rating from JMP Securities
In a filing, Werewolf Therapeutics Inc revealed its Director EVNIN LUKE unloaded Company’s shares for reported $40012.0 on Nov 19 ...
Analysts review Werewolf Therapeutics Inc’s rating
Werewolf Therapeutics Inc’s recent filing unveils that its Director EVNIN LUKE unloaded Company’s shares for reported $57205.0 on Nov 13 ...
HOWL price target predicted to rise nearly 12 in 12 months
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Werewolf Therapeutics ...
HOWL’s latest rating updates from top analysts.
Werewolf Therapeutics Inc’s recent filing unveils that its Shareholder MPM Asset Management Investors acquired Company’s shares for reported $5867.0 on ...
Werewolf Therapeutics Inc [HOWL] Investment Guide: What You Need to Know
Werewolf Therapeutics Inc’s filing revealed that its Shareholder MPM Asset Management Investors acquired Company’s shares for reported $7928.0 on Oct ...
